Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anita S. Jorna"'
Autor:
Niven Mehra, Frank Linschoten, Laurens V. Beerepoot, Henk M.W. Verheul, Ton Lisman, Emile E. Voest, Anita S. Jorna
Publikováno v:
Cancer Letters. 213:241-248
Numbers of circulating endothelial cells (CECs) are increased in cancer patients with progressive disease. Also, cancer patients have an increased risk for thrombotic events, being negatively associated with prognosis. Tissue factor (TF), the physiol
Autor:
Martijn F.B.G. Gebbink, Henk M.W. Verheul, Henk J. Broxterman, Klaas Hoekman, Anita S. Jorna, Herbert M. Pinedo
Publikováno v:
Blood. 96:4216-4221
Coagulation abnormalities, including an increased platelet turnover, are frequently found in patients with cancer. Because platelets secrete angiogenic factors on activation, this study tested the hypothesis that platelets contribute to angiogenesis.
The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery
Autor:
Emile E. Voest, Niven Mehra, Martijn P. Lolkema, Anita S. Jorna, Moniek van Beest, Rachel H. Giles
Publikováno v:
Experimental Cell Research, 301, 139-46
Experimental Cell Research, 301, 2, pp. 139-46
Experimental Cell Research, 301, 2, pp. 139-46
Item does not contain fulltext The von Hippel-Lindau (VHL) protein protects microtubules (MTs) from destabilization by nocodazole treatment. Based on this fixed-cell assay with static end points, VHL has been reported to directly stabilize the MT cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4f467cb148a8e4f1b46ad87cc7525c
http://hdl.handle.net/2066/59257
http://hdl.handle.net/2066/59257
Autor:
Yvette, van Hensbergen, Henk J, Broxterman, Roeland, Hanemaaijer, Anita S, Jorna, Natascha A, van Lent, Henk M W, Verheul, Herbert M, Pinedo, Klaas, Hoekman
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(12)
On the basis of the finding of marked overexpression in angiogenic microvessels, aminopeptidase N/CD13 has recently been suggested to play a prominent role in tumor angiogenesis. A soluble form of CD13 (sCD13) is present in human plasma, but its role